SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-24-020684
Filing Date
2024-04-19
Accepted
2024-04-19 08:32:38
Documents
21
Period of Report
2024-05-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A edge20022607x1_def14a.htm   iXBRL DEF 14A 1818097
6 sig_vdver.jpg GRAPHIC 11724
7 edge20022607x1_graphic0x1.jpg GRAPHIC 1048819
8 edge20022607x1_graphic0x2.jpg GRAPHIC 360771
9 edge20022607x1_pc01ax1.jpg GRAPHIC 548547
10 edge20022607x1_pc02ax1.jpg GRAPHIC 494431
11 edge20022607x1_pvp-barchart1.jpg GRAPHIC 176664
12 edge20022607x1_pvp-barchart2.jpg GRAPHIC 163767
  Complete submission text file 0001140361-24-020684.txt   9837419

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION - SCHEMA vir-20240529.xsd EX-101.SCH 6296
3 INLINE XBRL TAXONOMY EXTENSION - DEFINITION LINKBASE vir-20240529_def.xml EX-101.DEF 8219
4 INLINE XBRL TAXONOMY EXTENSION - LABEL LINKBASE vir-20240529_lab.xml EX-101.LAB 16494
5 INLINE XBRL TAXONOMY EXTENSION - PRESENTATION LINKBASE vir-20240529_pre.xml EX-101.PRE 10933
24 EXTRACTED XBRL INSTANCE DOCUMENT edge20022607x1_def14a_htm.xml XML 198732
Mailing Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158
Business Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39083 | Film No.: 24855696
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)